Impact of protein and small molecule interactions on kinase conformations.
biochemistry
cell-based reporter assay
chemical biology
dark kinome
drug interactions
enzyme reactivation
hard-to-target enzymes
kinase complex formation
kinase conformation
kinase scaffolding function
none
pseudo enzymes
target engagement
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
1
8
2024
Statut:
epublish
Résumé
Protein kinases act as central molecular switches in the control of cellular functions. Alterations in the regulation and function of protein kinases may provoke diseases including cancer. In this study we investigate the conformational states of such disease-associated kinases using the high sensitivity of the kinase conformation (KinCon) reporter system. We first track BRAF kinase activity conformational changes upon melanoma drug binding. Second, we also use the KinCon reporter technology to examine the impact of regulatory protein interactions on LKB1 kinase tumor suppressor functions. Third, we explore the conformational dynamics of RIP kinases in response to TNF pathway activation and small molecule interactions. Finally, we show that CDK4/6 interactions with regulatory proteins alter conformations which remain unaffected in the presence of clinically applied inhibitors. Apart from its predictive value, the KinCon technology helps to identify cellular factors that impact drug efficacies. The understanding of the structural dynamics of full-length protein kinases when interacting with small molecule inhibitors or regulatory proteins is crucial for designing more effective therapeutic strategies.
Identifiants
pubmed: 39088265
doi: 10.7554/eLife.94755
pii: 94755
doi:
pii:
Substances chimiques
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
BRAF protein, human
EC 2.7.11.1
Protein Kinase Inhibitors
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
Protein Kinases
EC 2.7.-
AMP-Activated Protein Kinase Kinases
EC 2.7.11.3
STK11 protein, human
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Universität Innsbruck
ID : WS104004
Organisme : Universität Innsbruck
ID : WS104005
Organisme : Horizon 2020 Framework Programme
ID : cONCReTE (872391)
Organisme : Austrian Science Fund
ID : 10.55776/P30441
Organisme : Austrian Science Fund
ID : 10.55776/P32960
Organisme : Austrian Science Fund
ID : 10.55776/P35159
Organisme : Austrian Science Fund
ID : 10.55776/I5406
Organisme : Österreichische Forschungsförderungsgesellschaft
ID : 877163
Informations de copyright
© 2024, Kugler, Schwaighofer et al.
Déclaration de conflit d'intérêts
VK, SS, AF, FE, JF, SS, SS, RW, JT, VS, PM, TK No competing interests declared, PT, ES ES and PT are co-founders of KinCon biolabs; KinCon-reporters are subject of patents (WO2018060415A1)